If you live in the U.K. and suffer from ankylosing spondylitis, you had better live in Scotland.
The National Institute for Health and Clinical Excellence (NICE), the national drug rationing body, has ruled that infliximab, has ruled that the drug is not cost effective. At £15,000 ($30,000) a year it is £5,000 ($10,000) a year more [...]
